EGFR Exon 19 Deletion Mutations and Systemic/CNS Miliary Metastasis: Clinical Correlations and Response to Therapy

Ítems similars

• Erlotinib response in a NSCLC patient with a novel compound G719D+L861R mutation in EGFR
  per: Berge, Eamon M, et al.
  Publicat: (2013)
• Targeted Therapies in NSCLC: Emerging oncogene targets following the success of EGFR
  per: Berge, Eamon M, et al.
  Publicat: (2013)
• Squamous Cell Carcinoma of the Lung with Metastasis to the GI Tract Associated with EGFR Exon 19 Deletion
  per: Weiss, Glen J., et al.
  Publicat: (2013)
• Detection of drug-sensitizing EGFR exon 19 deletion mutations in salivary gland carcinoma
  per: Dahse, R, et al.
  Publicat: (2008)
• Structural characterization of EGFR exon 19 deletion mutation using molecular dynamics simulation
  per: Tamirat, Mahlet Z., et al.
  Publicat: (2019)